上海市人群2002—2006年肝癌生存率分析

doi:10.19401/j.cnki.1007-3639.2016.07.001

中国癌症杂志 ›› 2016, Vol. 26 ›› Issue (7): 561-568.doi: 10.19401/j.cnki.1007-3639.2016.07.001

上海市人群2002—2006年肝癌生存率分析

彭　慧¹，郑　莹²，彭　鹏²，王春芳²，龚杨明²，吴春晓²，鲍萍萍²，顾　凯²，黄哲宙²，张敏璐²，向梅²

1. 上海市嘉定区疾病预防控制中心慢性病防治科，上海201800 ；
2. 上海市疾病预防控制中心肿瘤防治科，上海 200336

出版日期:2016-07-30 发布日期:2016-08-22
通信作者: 郑　莹　E-mail:zhengying@scdc.sh.cn

Survival analysis of liver cancer between 2002 and 2006 in Shanghai

PENG Hui¹, ZHENG Ying², PENG Peng², WANG Chunfang², GONG Yangming², WU Chunxiao², BAO Pingping², GU Kai², HUANG Zhezhou², ZHANG Minlu², XIANG Yongmei²

1.Department of Chronic Diseases Control and Prevention, Center for Disease Control and Prevention of Jiading District, Shanghai 201800, China; 2.Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China

Published:2016-07-30 Online:2016-08-22
Contact: ZHENG Ying E-mail: zhengying@scdc.sh.cn

摘要/Abstract

摘要： 背景与目的：我国是肝癌高发地区。上海市最新监测数据显示，肝癌发病率居恶性肿瘤发病前列，疾病负担仍很大。该研究旨在分析上海地区肝癌患者生存率情况，为肝癌的防治提供基础数据。方法：根据上海市肿瘤登记处收集的2002—2006年肝癌登记和生存随访报告资料，采用寿命表法和Ederer Ⅱ法对肝癌患者的观察生存率(observed survival，OS)和相对生存率(relative survival，RS)及其相关人口学和疾病状况特征资料进行分析。结果：纳入分析的上海市2002—2006年诊断的肝癌病例20 702例，1~5年OS分别为32.03%、21.63%、16.51%、13.66%和11.72%，1~5年RS分别为34.21%、23.93%、19.18%、16.84%和15.45%。男性OS较女性OS高，0~34岁年龄段患者OS高于其他年龄组，肝细胞癌的OS高于其他类型，Ⅰ期患者的OS明显高于Ⅲ期和Ⅳ期，市区和郊区居住肝癌患者生存情况差异无统计学意义(P<0.05)。过去30多年来，上海市肝癌患者5年OS和RS改善明显。结论：上海市肝癌患者的生存水平上升明显，但与其他常见恶性肿瘤相比，生存率仍较低，因此，进一步加强危险因素和高危人群的控制和干预是今后肝癌防治工作的重点。

关键词: 肝癌, 观察生存率, 相对生存率

Abstract: Background and purpose: China is a high incidence area of liver cancer. The latest monitoring data in Shanghai show that liver cancer is one of the most common cancers with very high disease burden. This study aimed to describe and analyze the population-based survival rates of patients with liver cancer in Shanghai. Methods: Data of liver cancer cases diagnosed between 2002 and 2006, including follow-up information and death report, were collected from Shanghai Cancer Registry. Life table and Ederer Ⅱ were used to calculate observed survival (OS) and relative survival (RS). The related demographic characteristics and status were also analyzed to reflect the survival situations of the liver cancer survivors in major areas of Shanghai. Results: In this study, 20 702 liver cancer cases were included in analysis. Five-year OS rate for liver cancer was 11.72%, whereas RS rate was 15.45%. The OS of male liver cancer patients was higher than that of female patients. Patients whose age ranged from 0-34 years had the highest survival rates than patients from other age groups. The survival of patients with hepatocellular carcinoma was higher than that of patients with other histologic types of liver cancer. Significant difference in survival had also been found among patients with various stages of liver cancer. The survival rate of patients with stageⅠliver cancer was much higher than that of patients with stage Ⅲ and Ⅳ liver cancers. There was no significant difference in the survival of liver cancer patients between urban and rural residents. Over the past 3 decades, the 5-year OS increased dramatically in Shanghai. Conclusion: The survival of patients with liver cancer in Shanghai is improved significantly. The prognosis is poor compared with other common malignant tumors. It is necessary to strengthen the risk factors and high-risk population control and intervention in the future.

Key words: Liver cancer, Observed survival, Relative survival

彭　慧,郑　莹,彭　鹏,等. 上海市人群2002—2006年肝癌生存率分析[J]. 中国癌症杂志, 2016, 26(7): 561-568.

PENG Hui, ZHENG Ying, PENG Peng, et al. Survival analysis of liver cancer between 2002 and 2006 in Shanghai[J]. China Oncology, 2016, 26(7): 561-568.

[1]	欧阳晓春 , 邹叶青 , 李玉梅 , 丁小兵 . ARHGAP4通过调控HK2表达促进肝癌细胞生长的研究[J]. 中国癌症杂志, 2020, 30(7): 481-487.
[2]	雷海科, 廖忠莉, 李小升, 周　琦, 赵玉兰, 何　美, 陈伟庆, 周　宏, 张　维, 吴永忠 . 重庆市食管癌患者生存随访调查及预后影响因素研究[J]. 中国癌症杂志, 2020, 30(2): 98-105.
[3]	杨　颖，杨志芳，才　层，张瑞丽，路鹏霏，贾春丽，李志鹏，毛　睿，张　华，包永星. miR-27a-3p对肝癌细胞化疗敏感性的影响及机制探讨[J]. 中国癌症杂志, 2019, 29(10): 788-794.
[4]	马荣,朱辉,龚建平. 基于倾向性评分匹配法的经导管肝动脉化疗栓塞联合高强度聚焦超声治疗肝癌的生存情况分析[J]. 中国癌症杂志, 2018, 28(4): 282-289.
[5]	李会琴,吴欣爱,董文杰,等. MARK2在肝癌中的表达及其对肝癌细胞迁移的影响[J]. 中国癌症杂志, 2018, 28(10): 733-739.
[6]	缪欣,丁岚,刘浩,等. miR-16对人肝癌细胞BEL-7402增殖与凋亡的影响[J]. 中国癌症杂志, 2018, 28(1): 38-42.
[7]	林镇海,闫士灿,张洁筠,等. MST4通过激活MAPK-ERK信号通路调节炎症因子释放促进肝癌的侵袭和转移的机制研究[J]. 中国癌症杂志, 2017, 27(9): 681-686.
[8]	张敏璐,吴春晓,龚杨明,等. 上海人群肺癌生存率分析[J]. 中国癌症杂志, 2017, 27(5): 326-333.
[9]	党中峰,何科基,那光玮,等. 靶向肝癌细胞自噬提高大黄素的毒性杀伤作用[J]. 中国癌症杂志, 2017, 27(3): 186-190.
[10]	李靖,肖金成,郑琳,等. 含洛铂方案经肝动脉化疗栓塞联合¹²⁵I粒子植入术治疗不能手术的中晚期肝癌的疗效观察[J]. 中国癌症杂志, 2017, 27(11): 896-902.
[11]	彭　鹏,吴春晓,龚杨明,等. 上海人群胃癌生存率研究[J]. 中国癌症杂志, 2016, 26(5): 414-420.
[12]	傅敬忠,黄龙璋,于　强,等. IGF-1R基因通过调控BMP2表达影响SMMC7721细胞的增殖和凋亡[J]. 中国癌症杂志, 2016, 26(4): 297-302.
[13]	董　婧,程　文,王秋程,等. 实时剪切波弹性成像在肝癌热消融应用中的初步体会[J]. 中国癌症杂志, 2016, 26(2): 145-150.
[14]	曾新桃,罗　华,张　伟,等. 小肝癌合并脾功能亢进的微创治疗的方法探讨[J]. 中国癌症杂志, 2016, 26(2): 177-181.
[15]	龚杨明,吴春晓,张敏璐,等. 上海人群结直肠癌生存率分析[J]. 中国癌症杂志, 2015, 25(7): 497-504.

上海市人群2002—2006年肝癌生存率分析

Survival analysis of liver cancer between 2002 and 2006 in Shanghai

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价